Transcenta licenses HiCB bioprocessing technology to WuXi Biologics for RMB 10 million upfrontPUBT·16 hours agoWXXWY-3.63%06628-10.71%
Chuangxin's Massive 166% Profit Surge Exposes Deep Divide in Hong Kong Mid-CapsGlobal Report·1 day ago, 11:32 AM01372+1.15%02178+1.96%
HK Market Divergence: Coal Supply Chains Surge as Real Estate Overhauls ContinueGlobal Report·1 day ago, 09:19 AM02178+1.96%02279+0.25%
HK Mid-Caps Diverge as China Feihe Revenues Surge While IGG Declares DividendGlobal Report·Sep 1 at 11:33 AM038180.00%026270.00%
Executive Sell-Offs and Web3 Pivots: Inside the Strategic Shifts Reshaping Hong Kong’s Mid-Cap LandscapeGlobal Report·Sep 1 at 09:17 AM03998+1.04%038180.00%
Transcenta files list of directors, board committee roles and disclosure-responsible managementPUBT·Aug 28 at 02:54 PM06628-10.71%
Transcenta appoints Prof. Genhong Cheng as independent non-executive directorPUBT·Aug 28 at 02:52 PM06628-10.71%
Transcenta HY26 net loss narrows to RMB 67.35 million; revenue more than doubled to RMB 23.6 millionPUBT·Aug 28 at 01:16 PM06628-10.71%
AI Infrastructure Fuels HK Industrials While Mid-Caps Pivot to Tech NarrativesGlobal Report·Aug 25 at 09:20 AM01372+1.15%01286-6.28%
Transcenta Calls Extraordinary Meeting to Approve Asset Purchase DealTip Ranks·Aug 24 at 10:39 PM06628-10.71%
Transcenta Holding announces extraordinary general meetingPUBT·Aug 24 at 10:06 PM06628-10.71%WXXWY-3.63%
Hua Medicine Warns on Profit as Wanka Online Raises HKD 350 Million for AI PushGlobal Report·Aug 19 at 09:43 AM01762-0.47%02552-2.82%
HK Real Estate Faces Brutal Delisting Wave as Capital Pivots to AI and Battery InfraGlobal Report·Aug 19 at 09:42 AM03336-2.03%01372+1.15%
Transcenta sets board meeting to review interim results, dividend proposalPUBT·Aug 12 at 08:35 AM06628-10.71%
